EP438: What on Earth is EECP and how can it help?

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Episode Introduction In this episode, Dr. Warrick Bishop, a cardiologist and CEO of the Healthy Heart Network, speaks with Jack Clifford, a 52-year-old former military professional from Florida. Jack suffered a severe heart attack in 2020 with three blocked coronary arteries and, facing emergency bypass surgery, chose to explore an alternative therapy called Enhanced External Counterpulsation (EECP). The conversation centers on Jack's personal journey with EECP and the broader potential of this lesser-known medical technology. Key Takeaways: EECP (Enhanced External Counterpulsation) uses compression cuffs on the legs to push blood upward toward the heart during diastole (the heart's rest phase), improving coronary blood flow without surgery. Jack had three coronary arteries blocked to a degree deemed unsuitable for stenting, making bypass surgery the standard recommendation — a route he ultimately declined. Concerns about cognitive decline following bypass surgery, witnessed through his mother's experience, motivated Jack to seek an alternative treatment path. EECP stimulates the release of vascular endothelial growth factor (VEGF) and hematopoietic stem cells, encouraging the body to grow its own new blood vessels over time. The therapy is described as functioning like cardiovascular exercise at "supra-physiologic" levels — delivering benefits beyond what even a highly fit person could achieve through normal exercise. Benefits of EECP extend well beyond cardiac care, with research suggesting positive effects on erectile dysfunction, kidney function, and cognitive decline, including a 2023 study showing reversal of dementia symptoms. Jack has accumulated approximately 700 hours on EECP — potentially more than any other individual — and reports significant improvements in organ function and visible increases in vascularity throughout his body. Despite being one of the most researched medical devices available, EECP remains largely unknown, even among medical professionals, and access is severely limited in the United States compared to countries like India and China. The standard clinical protocol of 35 hours of EECP treatment, while beneficial, may significantly underestimate the therapy's full potential, as Jack's extended use suggests compounding benefits over hundreds of hours. The mechanism of shear stress on blood vessel walls — triggered by the pressure differentials created by EECP — appears to be a key driver of new blood vessel growth throughout the body.